Introduction
New vessel formation plays a critical role in embryonic development and disease progression of adult organisms. The mechanism is complex and consists of multiple stages that include primary plexus formation, network expansion, and vascular remodelling. 1, 2 During the initial phase of new vessel formation, maturing endothelial cells (ECs) establish cellcell interaction to form multi-cellular structures that are gradually remodelled into microvascular tubules with open lumina. This critical step is orchestrated by mobilizing the EC's actin cytoskeleton to facilitate cell-morphological adaptations that are crucial for intercellular junction assembly. The importance of small GTPases in these processes has been previously investigated 3 : Rac1 is implied to be the predominant GTPase involved in VEGFA mediated angiogenesis, 4 and is crucial for lumen and tubule formation. Rac1 also facilitates migration as it controls actin polymerization during the formation of lamellopodia, 5 and knockdown of Rac1 in mice led to embryonic lethality as a result of defects in vascular growth. 6 In addition, cdc42 and Rac1 regulate endothelial barrier function by modulating the interaction between the actin cytoskeleton and junctional proteins like Ve-cadherin, located at adherence junctions. 7, 8 Rho family GTPases constantly cycle between the guanine diphosphate bound inactive state and the guanine triphosphate (GTP) bound active state. Their activity is tightly regulated by their activators Guanine Exchange Factors (GEF), and their inhibitors, which include GTPase activation proteins and guanine-diphosphate-disassociation inhibitors. 9 Cingulin is a 140 kDa protein, which is ubiquitously expressed in different cell types with high expression levels detected in epithelial cells of various origins. In vitro studies in canine renal epithelial cells demonstrates that cingulin is localized at the cytoplasmatic surface of tight junctions where it functions as an adaptor protein for GEFs. 10 Cingulin binds to actin filament bundles, suggesting that cingulin may be a linking protein between tight junction complexes and the actin cytoskeleton. However, although cingulin depletion promotes RhoA activity, it does not affect tight junction complex formation or actin cytoskeleton assembly. 10, 11 Cingulin-like 1 (Cgnl1), a 150-160 kDa paralogue of cingulin, also known as JACOP and PCING, was recently discovered to be localized in both adherens and tight junctions. Cgnl1 was shown to be an inhibitor of RhoA activity, but was also involved in the activation of Rac1 by the GEF Tiam1 in epithelial cells. 10, 12 Like cingulin, Cgnl1 is co-localized with actin filament bundles, implying that it could be a cross-road modulator that links intercellular junction assembly to actin cytoskeleton-regulated morphogenesis, both key processes in angiogenesis. Indeed, Cngl1 mRNA expression has been detected in CD31þ cells isolated from mouse embryos on days 8.5 and 9.5, in which it was preferentially expressed in endocardial cells, but not yolk sac ECs. 13 Previously, we conducted a genome-wide transcriptomic screen with the goal to identify new molecular regulators of vascular development during murine embryogenesis. 14 In line with the previous report, we found that unlike cingulin, Cgnl1 was mainly expressed in Flk1þ endothelial precursor cells during embryonic development. Cgnl1 has been indicated to be actively involved in tight junction regulation of ECs. 15 Here we further assessed the role of Cgnl1 in EC biology and angiogenesis.
Our data demonstrate that Cgnl1 promotes angiogenesis by strengthening adherens junctions via Rac1 activation, which leads to stabilization and further elongation of newly formed vascular tubules.
Methods

Mouse retinal angiogenesis model
Approval was granted by the institutional ethics review board (DEC 109- [11] [12] . All animal procedures were conducted conform the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes. Two or 8-days old C57bl/ 6 pups were anesthetized by placement on ice. For Cgnl1 silencing experiments, 100 nmol accel siRNA targeting murine Cgnl1 was intravitreally injected in the left, and 100 nmol accel scrambled non-tageting siRNA in the right eye (Dharmacon, Netherlands) in a volume of 0.5 ll using a 33-gauge needle. At Day 6 or 12 post-transfection, pups were sacrificed by decapitation, and retinas were stained with FITC isolectin IB4 (1:200). Angiosys analysis software (Angiosystems, UK) was used to determine total tubule length, and the number of tubules and junctions per field of view. Adequate target mRNA inhibition was validated by qPCR analysis and western blot analysis.
In vitro culture
Human Umbilical Vein ECs (HUVECs; Lonza) and Human Brain Vascular Pericytes (HBVPs; Lonza) were cultured on gelatine-coated plates in EGM2 medium (EBM2 medium supplemented with EGM2 bullet kit and 2% FCS; Lonza) and DMEM (10% FCS; Lonza) respectively, in 5% CO 2 at 37 C. The experiments were performed with cells at Passage 3-5.
Lentiviral transfected HUVECs that express green fluorescent protein (GFP) were used at Passage 6-8.
Statistical analysis
Results are expressed as the mean ± SD and statistical analysis was performed by one-way ANOVA followed by tukey's post-hoc test, or Student's t-test where appropriate. P < 0.05 was considered significant.
More detailed descriptions of the material and methods used in this study are provided in the Supplementary Material.
Results
Cgnl1 shows predominant expression in developing vascular structures
Cgnl1 was mainly expressed in the (fetal kinase receptor 1) Flk1þ cell population during embryonic development in mice as shown by qPCR validation of microarray screen data ( Figure 1A) . Cgnl1 was predominantly expressed in Flk1þ endothelial precursor cells at 9.5 days postcoitus during which the majority of the vascular structures in the embryo are established ( Figure 1A) . This finding was further confirmed by datamining of public expression databases (NCBI, Gene Expression Omnibus: see Supplementary material online, Figure S1A and B), which showed higher expression levels of Cgnl1 in primary ECs of different origins compared with the more epithelial enriched expression of cingulin.
Next, whole mount in situ hybridization was conducted using a probe that targeted the zebrafish orthologue of Cgnl1 in the larval stages. At 24 h post-fertilization (hpf), Cgnl1 expression was observed in the trunk region in the dorsal aorta (DA) and post-cardinal vein with low expression in the intersegmental vessels ( Figure 1B and D) . In the head region, Cgnl1 was clearly expressed in the bi-lateral aorta Y-trunk and the cranial vasculature ( Figure 1E and C). From 48 hpf onward, Cgnl1 expression was also observed in the heart ( Figure 1F ). The vascular expression pattern of Cgnl1 was similar to the vascular GFP pattern of Tg(kdrl; eGFP) y1 zebrafish larvae (see Supplementary material online, Figure S1C ). This vascular pattern of Cngl1 gradually declined during larvae maturation ( Figure  1F -I). Specific targeting of Cgnl1 by anti-sense probe was validated by comparing the anti-sense and sense probe signal (see Supplementary material online, Figure S1D and E). To assess if this vascular expression pattern was conserved in mammals, qPCR analysis was conducted on different organs in mature C57/bl6 mice. Endogenous murine Cgnl1 expression was significantly higher in the aorta and kidney as compared with heart, lung, liver, skeletal muscle, eye, and brain tissue ( Figure 1J) . In contrast, cingulin expression was not enriched in murine aorta ( Figure  1K ). HUVECs showed significant higher expression of Cgnl1 as compared with human pericytes, renal epithelial cells and fibroblasts (see Supplementary material online, Figure S1F ). In contrast, cingulin expression was more prominent in renal epithelial cells (see Supplementary material online, Figure S1G ). Immunohistological analysis demonstrated selective Cgnl1 expression in the endothelial lining of large blood vessels and microvessels in human samples ( Figure 1L ).
Cgnl1 is essential for neovascular tubule formation
Based on the vascular enriched expression profile of Cgnl1, we hypothesized that Cgnl1 contributes to vascular development. A standard 2Dmatrigel sprouting assay was conducted in which sprouting capacity of ECs was assessed. In this assay, ECs form cordlike structures consisting of one to three cells within 18 h, after which this initial network disintegrates due to the lack of stabilizing cues. Using siRNA that targeted endogenous Cgnl1 (siCgnl1) and scrambled siRNA as controls (sisham) in human primary HUVECs, the effect of Cgnl1 silencing on angiogenic sprouting potential was investigated. SiCgnl1 transfection significantly reduced endogenous Cgnl1 mRNA and protein levels as compared with sisham-transfected and nontransfected (control) HUVECs (see Supplementary material online, Figure S2A -D). In addition, siRNA targeting of Cgnl1 did not affect family member cingulin on either protein or mRNA level (see Supplementary material online, Figure S2E and F). Quantitative comparison between siCgnl1-transfected and sisham-transfected cells showed no difference in sprouting capacity in the 2D-matrigel assay (see Supplementary material online, Figure S2G and H).
As Cgnl1 did not seem to affect initial vascular sprouting, we proceeded to study Cgnl1 function in vascular tubule construction in the presence of mural cells that provide vascular stabilizing cues. Tubule formation experiments were conducted in a well-validated 3D collagen type I gel coculture system. In this assay, GFP marked HUVECs are cocultured with RFP labelled pericytes to enable assessment of a number of critical steps, including assembly of multicellular, lumenized branching vessels. The multicellular nature of neovessels obtained with this 3D coculture assay is demonstrated in Supplementary material online, Figure  S3A and B, and is shown in a time lapse movie (see Supplementary mate rial online Movie S1). The effect of Cgnl1 silencing by siRNA targeting in HUVEC was assessed at Days 2 and 5 (Figure 2A and B, and see Supplementary material online, Figure S3C ). Cgnl1 silencing (siRNA set 1) severely impeded the formation of new tubule structures as compared with non-transfected and sisham-transfected controls ( Figure 2B) . These results were further confirmed by using a second set of siRNA that targets Cgnl1 on different sequences ( Figure 2C and D) . In contrast, monocultures of HUVECs in 3D collagen matrix did not affect new tubule formation, indicating that pericyte interaction with ECs is important for the process of Cgnl1-mediated tubule formation (see Supplementary material online, Figure S4A -D). Cgnl1 expression was significantly upregulated in HUVECs that were cocultured with mural cells [vascular smooth muscle cells (VSMCs) or pericytes] as compared with HUVECs monocultures (see Supplementary material online, Figure S4E ). Evaluation of the expression profile of the HUVECs in coculture with pericytes revealed that downregulation of Cgnl1 in HUVECs diminished Angiopoietin 1 (Angpt1) and increased VEGFA expression, whereas VEGFR2, Angiopoietin 2, Tie1, and Tie2 expression levels remained unaffected (see Supplementary material online, Figure S4F ). In contrast, western blot analysis revealed no significant effect of Cgnl1 silencing on VEGFA and Angpt1 protein levels (see Supplementary material online, Figure S4G ). Cgnl1 silencing in HUVECs did not affect pericyte numbers (see Supplementary material online, Figure S5A ). Next, we assessed if induction of Cgnl1 expression in HUVECs is induced either by direct cell contact or paracrine stimulation by pericytes. HUVECs cultured on a thin porous membrane with direct contact of pericytes that are cultured on the other side show enhanced Cgnl1 expression versus HUVECs cultured without pericyte direct contact (see Supplementary material online, Figure S5B and C). In contrast, HUVECs cultured in the bottom well of a thin porous membrane insert in which percytes were seeded, allowing paracrine stimulation of HUVECs without direct pericyte contact, did not enhance Cngl1 expression versus HUVECs cultured in a similar setup without pericytes (see Supplementary material online, Figure S5D ) These data indicate that induction of Cgnl1 expression in HUVECs in response to pericytes is mediated via direct contact between the two cell types. EC and pericyte interaction can take place in peg-andsocket contacts via (CX43-mediated) gap and (N-cadherin-based) adherence junctions. 16 To further investigate via which interaction mechanism pericyte activation of Cngl1 in ECs is mediated, we evaluated Cngl1 expression in HUVECs in response to pericyte direct contact stimulation with siRNA mediated knockdown of CXC43 and N-cadherin. Silencing of these peg-and-socket enriched proteins in HUVECs and pericytes did not affect induction of Cgnl1 expression in HUVECs by pericyte contact (see Supplementary material online, Figure S5E and F). Recent findings also indicate ECs and mural cells communicate via crosscell type Notch ligand presentation, [17] [18] [19] initiating Notch signalling that promotes strong cell-cell contacts by Ve-cadherin immobalization at adherens junctions. [18] [19] [20] Indeed, siRNA mediated silencing of Notch1 and Notch4 and DLL4 in HUVECs and pericytes abolished Cgnl1 mRNA upregulation mediated by pericyte coculture (see Supplementary material online, Figure S5G -I). These data demonstrate that Cngl1 expression in ECs is enhanced via direct contact with pericytes via Notch signalling between the two cell types.
Cgnl1 silencing in vivo impedes retinal vasculature development in postnatal mice
To assess the in vivo relevance of these findings, the effect of Cgnl1 knockdown was studied in the developing retinal vasculature of postnatal C57/bl6 wildtype mice. Cgnl1 was silenced by injection of murine Cgnl1 targeting siRNA in the left and non-targeting siRNA in the right eye of 2-day-old pups. Injection of the non-targeting siRNA sequences did not affect retinal vascularization (data not shown). Silencing of Cgnl1 was verified by qPCR and western blot (see Supplementary material online, Figure S6A and B). At Day 6, the retinas were dissected and the vasculature was visualized by isolectin IB4 staining. Expansion of the vascular network from the neural plexus towards the retinal borders was impeded by Cgnl1 knockdown ( Figure 3A) . Assessment on higher magnification showed frequent malformation in the vascular structures and lower vessel density in siCgnl1 treated retinas ( Figure 3A) . Quantification of the vasculature showed decline in the number of vascular tubules, junctions, and in total tubule length ( Figure 3B ). Likewise, Cgnl1 silencing during a later timeframe (with injection at Day 8 after birth, during which a high density vascular network is well-established) compromised integrity of the vascular network, and further quantification showed a similar reduction in the number of tubules, junctions, and total tubule length at Day 12 ( Figure 3A and see Supplementary material online, Figure S6C ).
Cgnl1 silencing affects Rac1 and RhoA activity and decreases actin cytoskeleton assembly
It was previously reported that Cgnl1 is involved in the regulation of Rho-family GTPases activity in epithelial kidney cells. 12 Consequently, we assessed RhoA, cdc42 and Rac1 activities using ELISA-based activity assays. HUVECs were seeded on a thin layer of gelatin/collagen coating to provide an integrin-ECM contact trigger for GTPase activation, and were harvested after 20 and 40 min of stimulation for analysis. Cgnl1 silencing in HUVECs significantly reduced Rac1 activation early after cell seeding ( Figure 4A ), whereas RhoA activity was increased ( Figure 4A) . In contrast, no significant effect was observed in the activation of the small GTPase cdc42 in comparison to sisham-transfected controls ( Figure 4A ). Western blot analysis showed no difference in total Rac1, RhoA and cdc42 protein levels (see Supplementary material online, Figure S7A ). In line with the observation that Cgnl1 expression is increased in HUVECs Cngl1 in angiogenesis in response to pericyte stimulation, HUVECs cocultured with pericytes showed a significant increase in Rac1 activation versus single culture HUVECs (see Supplementary material online, Figure S7B ). In addition, silencing of Cngl1 in HUVECs abolished these effects of pericyte stimulation (see Supplementary material online, Figure S7C ). Our data showed that upregulation of Cgnl1 expression by pericyte contact in HUVECs was mediated via Notch signalling. Indeed silencing of Notch4 abolished the effects on Rac1 activity by pericyte stimulation of HUVECs (see Supplementary material online, Figure S7C ). These data demonstrate that Cngl1 upregulation in HUVECs by pericyte crosstalk with HUVECs via Notch signalling enhances endothelial Rac1 activity.
A delay in cell-morphological adaptation during adhesion of Cgnl1 silenced HUVECs implied that actin-cytoskeletal assembly in these cells was affected. To study this in more detail, siCgn1 and sisham transfected HUVECs were seeded on gelatin/collagen-coated glass slides, and morphological changes in the actin-cytoskeleton during cell adhesion were studied by phalloidin-Rhodamine staining at 10 and 20 min after seeding Figure 4B ). Cgnl1 knockdown caused a delay in actin-adaptation, identified by a significant decrease in the number of cells with a distinct flat morphology with clear actin-distribution at the cell periphery, and an increased in rounded cells with limited actin redistribution after 10 min of adhesion ( Figure 4C) . To further validate these findings, live imaging was conducted in the previously described 3D collagen type I gel coculture system. Cellular adaptation of GFP marked HUVECs was monitored for up to 50 time points post-initiation of the assay (1 time point = 1 h). Silencing of Cgnl1 in HUVECs-GFP reduced the morphological adaptive capacity of these cells, shown by a significant reduction in the siCgnl1 treated group in natural increase of aspect ratio (AR = major axis/minor axis) per GFPþ structure as observed in sisham treated controls, indicating a defect in cell elongation ( Figure 4D and E) . Similarly, the natural decrease in roundness per GFPþ structure was significantly reduced in the siCngl1 treated group (Figure 4D and E) . These results were further confirmed by using a second set of siRNA that targeted Cgnl1 on different sequences (see Supplementary material online, Figure  S7B) .
The observed effects of Cgnl1 silencing on neovessel formation could be caused by changes in EC proliferation or apoptosis. However, Cgnl1 silencing did not immediately affect EC proliferation, as shown by lack of difference in BRDU incorporation and cell cycle progression (see Supplementary material online, Figure S8A and B) between the sisham Figure  S8C ). Together, these data imply that the inhibitory effect of Cgnl1 silencing on vascular formation is not direct dependent on cell proliferation and apoptosis, but may be mediated by Rho-family GTPase regulation of cell morphology via modification of the cytoskeleton.
Cgnl1 silencing disrupts Ve-cadherin association with the actin cytoskeleton and impairs Ve-cadherin adherens junction stabilization
Co-localization of Cgnl1 with the actin cytoskeleton in kidney epithelial cells was previously reported. Here we assessed the intracellular localization of Cgnl1 in human ECs. Cgnl1 antibody staining showed colocalization of Cgnl1 with phalloidin-stained actin filaments in HUVEC cultures ( Figure 5A) . Protein association with the cytoskeleton can be evaluated by comparing the TritonX-100 insoluble with the TritonX-100 soluble fractions of cell extracts. 21 Comparison between the TritonX-100 soluble and insoluble compartment of confluent HUVEC cultures clearly showed a predominant presence of Cgnl1 in the Triton-X100 insoluble (cytoskeleton associated) fraction ( Figure 5B ). Soluble and insoluble fractions were adequately separated, as shown by predominant enrichment of VEGFA in the soluble fraction (see Supplementary material online, Figure S9A) .
Cgnl1 was previously shown to affect adherence junction stability via Rac1 activation in kidney epithelial cells. 12 Actin cytoskeleton association with Ve-cadherin is crucial for adherens junction formation and survival of the neovasculature. Hence, we evaluated the levels of Ve-cadherin in endothelial soluble and insoluble fractions. No difference was observed Cngl1 in angiogenesis in the soluble fraction between the groups ( Figure 5C) . In contrast, Cgnl1 silencing in confluent HUVEC monolayers significantly reduced the level of Ve-cadherin protein in the Triton-X100 insoluble (actin cytoskeleton associated) fraction as compared with the controls (Figure 5D ). Immunofluorescent microscopy revealed that Cgnl1 silencing affected Ve-cadherin localization at cell-cell contacts in confluent HUVEC monolayers in vitro. Thus, a significant decrease in Ve-cadherinþ adherens junction formation at the cell-cell borders was observed ( Figure 6A and B) . This decrease in Ve-cadherin recruitment at adherens junctions in the Cngl1 silenced condition was also observed when the confluent layer of HUVECs was in contact with mural cells (pericytes) (Figure 6C and D) . These data indicate that Cgnl1 promotes Ve-cadherin adherens junctions formation in ECs.
Cgnl1 silencing impairs FAK signalling and focal adhesion complex assembly
Except for modulation of cell-cell junctions, Rac1 is a known key modulator of integrin-focal adhesion complex assembly, a process that plays a prominent role in EC morphological adaptation during tubule formation. Indeed activated (GTP bound) Rac1 was found to be recruited to initial focal adhesion sites. 22 As Cgnl1 modulates Rac1 activation, and EC adhesion was affected in Cgnl1 silenced HUVECs, we hypothesized that Cgnl1 may also affect focal adhesion complex assembly in response to EC-extracellular matrix (ECM) contact. We investigated the effect of Cgnl1 silencing on focal adhesion-assembly in the response to cell-ECM interaction. Immunofluorescent intracellular staining was conducted on siCgnl1 or sisham treated HUVECs at 30, 60, and 120 min after seeding on gelatin/collagen coated glass slides. A significant defect in assembly of focal adhesion-structural proteins paxillin and vinculin ( Figure 7C-F) were observed in Cgnl1 silenced HUVECs at 60-min post-seeding as compared with sisham controls (Figure 7C-F) . Recruitment and activation of FAK at nascent focal adhesion sites is required to strengthen and maturate the focal adhesion complex. Intracellular staining revealed that Cgnl1 silencing inhibited FAK recruitment at focal adhesion sites at 30, 60 and 120 min post-seeding ( Figure 7A and B) . This decrease in focal adhesion assembly in Cgnl1 silenced condition was also observed when the confluent layer of HUVECs was cultured in contact with mural cells (pericytes) (see Supplementary material online, Figure S9B and C), as shown by paxillin analysis.
Western blot analysis also showed a significant decrease in vinculin, but not paxillin protein levels (see Supplementary material online, Figure  S9D ), indicating that the effects observed for vinculin may be directly linked to a reduction in vinculin protein. Western blot analysis showed no changes in total FAK protein levels in Cgnl1 silenced ECs (see Supplementary material online, Figure S9E) . In contrast, a decline in phospho-Y397-FAK levels in siCgnl1-treated cells compared with sisham-treated controls was observed at 20 min after seeding ( Figure  7G) , indicative of a reduction in FAK activation. Downstream activation of C-Src was impeded by Cgnl1 knockdown as well, shown by a decrease in phospho-Y418-C-Src at 40 min post-seeding, whereas total C-Src remained unaffected ( Figure 7H and see Supplementary material online, Figure S9E ). Combined, these data indicate that Cgnl1 silencing in ECs diminishes focal adhesion assembly and FAK signalling in response to EC-ECM contact. These perturbations in the basic pathways of cell morphological adaption, in addition to the observed diminished assembly of Ve-cadherin adherens junctions, could induce instability of neovasculature and negatively affect the capacity of neovessels for further growth. To evaluate this concept, time lapse live imaging was conducted in the 3D collagen type I gel coculture system. GFPþ vascular structures were monitored for up to 125 time points post initiation of the assay (1 time point = 1 hour). Although in the early time points (<25 time points/h), no difference in area per GFPþ structure between siCngl1 and sisham groups was observed, silencing of Cgnl1 in HUVECs-GFP at later time points (>25 time points/h) significantly reduced the natural size increase per GFPþ vascular structure that was observed in sisham coculture conditions, indicating reduced tubule stability ( Figure 7I and J) . Finally, these results were further confirmed by using a second set of siRNA that targeted Cgnl1 on different sequences (see Supplementary material online, Figure S9F ).
Discussion
In this study we report several findings: (i) Unlike cingulin, Cgnl1 expression is mainly enriched in ECs during vascular growth. (ii) Cgnl1 is pivotal for stable tubule structure formation during new vessel formation, as shown in vitro using loss-of function studies in a 3D matrix co-culture system that uses primary human ECs and supporting mural cells. (iii) Cgnl1 is critical for vascular growth in vivo, as shown in the murine retina vascularization model. (iv) Cgnl1 in ECs promotes Ve-cadherin association with the actin cytoskeleton and induces adherens junction stabilization.
(v) Cgnl1 promotes focal adhesion assembly in response to ECs-ECM contact. To our knowledge this is the first study to identify Cgnl1 as an important regulator of new vessel formation both in vitro and in vivo. It also provides new evidence for the involvement of Cngl1 in the regulation of Ve-cadherin assembly at adherens junctions in ECs.
High level of expression of Cgnl1 in ECs
Cgnl1 was reported to be highly expressed in renal epithelial cells. 12, 23 We detected significant higher Cgnl1 expression levels in Flk1þ (ECs) versus Flk1-(non-ECs) at different stages of mouse embryo development. Using in situ hybridization we showed that Cngl1 expression in developing zebrafish larvae is mainly observed in vascular structures. In human bloodvessels, we detected a strong endothelial Cngl1 signal by immunochemistry. Our observations are in line with the findings of Narumiya et al., 13 who reported that Cgnl1 was highly expressed in CD31þ (endothelial) cells in mouse embryos on embryonic day (E)8.5 and E9.5. These data imply a role for Cngl1 in the regulation of EC function.
Cgnl1 regulates stable tubule structure formation and proves crucial for in vitro and in vivo angiogenesis
Cgnl1 has been implicated to be involved in the regulation of EC junctions: In a study focussed on the regulation of ZO-1 in cultured human dermal microvascular cells (HDMEC), Tornavaca et al. 15 reported that Cgnl1 was located at tight junctions of confluent HDMEC monolayers. ZO-1 silencing in HDMECs led to reduced localization at tight junctions of Cngl1, whereas Cngl1 silencing led to redistribution of vinculin from cell junctions to focal adhesions and promoted stress fibers formation. ZO-1 and p114rhoGEF were shown to co-immunoprecipitate with Cgnl1, indicating direct binding between these proteins. Combined, the data of Tornavaca et al. indicate that p114RhoGEF together with ZO-1 and Cngl1 stimulate junctional actomyosin activation, leading to coupling of mechanotransducers to the tight junction complex, thereby ensuring barrier function of the endothelium. However, no direct evidence was provided to demonstrate a role for cngl1 in the process of angiogenesis, and in particular tubule structure formation.
In our study, we provide for the first time both in vitro (3D coculture assay) and in vivo data (murine retina vascularization model) that demonstrate that Cgnl1 silencing significantly inhibits the angiogenic capacity of vascular cells. Cgnl1 silencing greatly impaired tubule structure formation in the 3D coculture assay, and diminished the number of vascular structures formed during vascular expansion in the developing retina.
Cgnl1 in ECs promotes Ve-cadherin association with the actin cytoskeleton and induces adherens junction stabilization
The molecular mechanism of Cgnl1 has been mainly investigated in vitro in epithelial kidney cells, although it has also been shown in cultured urotherial cells that expression levels of Cngl1 is tightly regulated by miR-205. 24 In renal epithelial cells, Cgnl1 was identified as a cell-cell junctional complex adaptor protein. 10, 12 After recruitment of Cngnl1 to the tight junctions via ZO-1, Cgnl1 promotes Rac1 activation via Tiam1, and inhibits RhoA activity by GEFH1 inhibition. 12 Other studies have also indicated that Cgnl1 localizes in adherens junctions. 10, 25 Only one study reported the function of Cngl1 in vascular endothelial cells (HDMECs). Similar to the findings in epithelial kidney cells, this study in HDMECs demonstrated a regulatory role for ZO-1 in tight junction recruitment of Cgnl1. 15 In our study, we focused on the regulation of Cgnl1 of adherens junctions via GTPases and actomyosin regulation. In line with the findings in renal epithelial cells, our data showed that Cgnl1 silencing in HUVECs inhibited Rac1 and promoted RhoA activity respectively, which led to impaired Vecadherin colocalization with actin filaments at adherens junction sites. The actin cytoskeleton at the cell periphery is composed of a highly organized meshwork of filamentous actin, which is closely associated with the nearby plasma membrane with cell-cell junction and ECM-cell focal adhesion complexes. Intracellular Cgnl1 co-localized with actin filaments, 10, 12 and Cgnl1 knockdown delayed cadherin recruitment and subsequent adherens junction assembly in epithelial cells. Our findings demonstrate that Cgnl1 is colocalized with the actin cytoskeleton and is enriched in the Triton-X100 insoluble (actin cytoskeleton-associated) fraction in ECs. Knockdown of Cgnl1 induced Ve-cadherin-actin dissociation, implied by a decline in Vecadherin in the Triton-X100 insoluble compartment, and a decrease in Vecadherin accumulation at adherens junction sites. Combined with previous reported findings, the data demonstrate that Cgnl1 could affect vascular growth by promoting adherens junction stabilization.
Cgnl1 promotes focal adhesion assembly in response to ECs-ECM contact
Focal adhesions are dynamic protein complexes that provide a linkage point between the cells extra-and intra-cellular environment, playing a central role in migration and cell adhesion. 26, 27 Rac1 deletion significantly inhibited focal adhesion assembly in mouse embryonic fibroblasts, whereas overexpression of an active RhoA mutant failed to rescue the observed phenotype. 26 In a transgenic mouse model, expression of a constitutively active form of Rac1 altered focal adhesion structures. 28 The previous study in HDMECs demonstrated a regulatory role of Cgnl1 in vinculin distribution to focal adhesions. In line with these observations, our study showed that Cgnl1 silencing impaired focal adhesion assembly, coinciding with a reduction in Rac1 activation.
Proposed mechanism for Cngl1 in neovessel formation
Based on our findings on the important role for Cgnl1 in vessel formation, we hypothesize that the main function of Cgnl1 during vascular growth is tubule formation by control of adherens junction and focal adhesion assembly via regulation of Rac1 activity. Initial contacts between ECs are relatively weak, with serrated Ve-cadherin junctions, providing ECs with high motility to respond to e.g. VEGFA gradients. 20, 29 In contrast, Notch signalling, provided either by neighbouring endothelial tip cells, or by pericytes via Notch ligand presentation, has been shown to promote the formation of strong cell-cell contacts with immobile straight Ve-cadherin junctions, that limit the migration capacity of the connected cells. 18, 20, 29 Based on our (live imaging) findings, which highlight the inhibitory effects of siCgnl1 on the capacity of ECs to undergo stable morphological adaptations to form and extend 3D neo tubule structures, Cngl1 could be mainly involved in the formation of strong Ve-cadherin junctions that promote immobile cell-cell connections in response to Notch signalling provided by pericytes, while it has a limited impact on initial weak (Ve-cadherin) bond formation. Indeed, our data demonstrate that Cngl1 expression in HUVECs is significantly enhanced by direct cell contact with pericytes. Furthermore, this induction of Cgnl1 expression in HUVECs is facilitated via Notch signalling, as knockdown of Notch1/4 and DLL4 in both cell types severely impeded the Cgnl1 induction in HUVECs in response to pericyte stimulation. Our data further demonstrate that Cngl1 upregulation in HUVECs by Notch signalling with pericytes enhances endothelial Rac1 activity. In further support of this concept, our analysis of the time lapse data indeed reveals that siCngl1 structures are more instable compared with sisham structures, negatively affecting the capacity of the individual neovessels for elongation beyond the two to three cell stage.
Thus, based on our current findings, we propose a working mechanism for Cngl1 in which pericyte-induced upregulation of Cngl1 in ECs via Notch signalling promotes the formation of strong Ve-cadherin adherens junctions via Rac1 activation. Simultaneously, Cngl1 mediated Rac1 activation stimulates assembly of integrins-focal adhesion complexes. Figure S10 ).
Limitations of the study
The use of siRNA to target Cgnl1 in the murine retinal vascularization model evokes a mild influx of IB4-possitive immune cells that may affect vascular growth. To be able to make a distinction between the effects that are the result of Cgnl1 inhibition and the effects that are linked to the use of siRNA, we injected the control retinas with a set of nontargeting siRNAs. As we compared non-targeting siRNA with Cgnl1 targeting siRNA-treated conditions, we consider the observed vascular phenotype, at least in part, to be the direct result of Cngl1 silencing, and not merely a side effect of immune cells activation by siRNA treatment itself. However, it cannot be entirely excluded that the observed effects of Cngl1 silencing in the murine retina model may have been facilitated by a background of increased immune activation. Although the Triton-X lysate separation method could help to distinguish soluble and insoluble fractions, our data set only provides evidence that Cngl1 is enriched in the same insoluble fraction as cytoskeletal actin, and does not show direct binding between Cngl1 and actin protein.
Conclusions
Cgnl1 mediates vascular growth by stabilizing newly formed vascular tubules via adherens junction stabilization in ECs. Stimulation of neovessels by recruited pericytes via cross-cell type Notch signaling enhances the Cgnl1-mediated stabilization process in ECs. Our findings support an important function of Cgnl1 in regulation of vascular growth during embryonic development and vascular-related disease in adulthood.
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